Evidence map›Paper›PMID 32170116›Full record

ArticleScientific reports2020

Circulating leptin levels are associated with adiposity in survivors of childhood brain tumors.

E Danielle Sims, William J Jennings, Brianna Empringham, Adam Fleming, Carol Portwine, Donna L Johnston, Shayna M Zelcer, Shahrad Rod Rassekh, Sarah Burrow, Lehana Thabane and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Nutrients · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

E Danielle SimsDepartment of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
William J JenningsDepartment of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
Brianna EmpringhamDepartment of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
Adam FlemingDepartment of Pediatrics, McMaster University, Hamilton, Ontario, Canada.ORCID http://orcid.org/0000-0002-7194-3220
Carol PortwineDepartment of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
Donna L JohnstonDivision of Pediatric Hematology/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
Shayna M ZelcerPediatric Hematology Oncology, Children's Hospital, London Health Sciences Center, London, Ontario, Canada.
Shahrad Rod RassekhDivision of Pediatric Hematology/Oncology/BMT, Department of Pediatrics, British Columbia Children's Hospital, Vancouver, BC, Canada.
Sarah BurrowDivision of Orthopedic Surgery, Department of Surgery, McMaster University Medical Centre, Hamilton, Ontario, Canada.
Lehana ThabaneDepartment of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
M Constantine SamaanDepartment of Pediatrics, McMaster University, Hamilton, Ontario, Canada. samaanc@mcmaster.ca.
McMaster Children's Hospital · CABC Children's Hospital · CAChildren's Hospital of Eastern Ontario · CALondon Health Sciences Centre · CAMcMaster University Medical Centre · CASt Joseph's Health Care · CA

Funding

Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) NARegional Medical Associates of Hamilton NA
6 · The paper itself

Abstract

Survivors of Childhood Brain Tumors (SCBT) are at a higher risk of developing cardiovascular disease and type 2 diabetes compared to the general population. Adiposity is an important risk factor for the development of these outcomes, and identifying biomarkers of adiposity may help the stratification of survivors based on their cardiovascular risk or allow for early screening and interventions to improve cardiometabolic outcomes. Leptin is an adipokine that positively correlates with the adipose mass in the general population and is a predictor of adverse cardiometabolic outcomes, yet its association with adiposity in SCBT has not been studied. The aim of this study was to determine if leptin levels are associated with the adipose mass in SCBT, and to define its predictors. This cross-sectional study included 74 SCBT (n = 32 females) with 126 non-cancer controls (n = 59 females). Total adiposity was measured using Bioelectrical Impendence Analysis (BIA) and central adiposity was measured using waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR). We used multivariable linear regression analysis to determine if leptin predicts adiposity in SCBT and adjusted for age, sex, puberty, and cancer status. Leptin correlated strongly with total (p < 0.001) and central (WHR p = 0.001; WHtR p < 0.001) adiposity in SCBT and non-cancer controls. In conclusion, leptin is a potential biomarker for adiposity in SCBT, and further investigation is needed to clarify if leptin is a predictor of future cardiometabolic risk in SCBT.

Indexed as

Brain NeoplasmsCancer SurvivorsAdiposityAdolescentBiomarkersCardiovascular DiseasesChildCross-Sectional StudiesDiabetes Mellitus, Type 2Early DiagnosisFemaleHumansLeptinMalePredictive Value of TestsRisk FactorsBiomarkersLeptin

Identifiers

PMID32170116
PMCPMC7070034
OpenAlexW3010770365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.